🔎 Trials Near Me

Home › Breast Cancer › NCT05130606

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

RecruitingHealthy volunteers welcome

Testing a Narrative Intervention to Enhance Genetic Counseling and Testing

Who can join

Ages 18 and older · Women · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

Aim 1 and 2.

* Self-identify as a Latina woman
* Be 18 years old or older
* Be able to provide informed consent
* Be fluent in Spanish
* Meet NCCN criteria to be considered for genetic cancer risk assessment for HBOC, whether by a personal history of cancer or family history of cancer
* No previous participation in genetic counseling or testing for hereditary breast and ovarian cancer risk
* No other family members are participating in this study
* Have not participated in any previous studies involving interventions about HBOC or GCT

Aim 3.

* Be 18 years old or older
* Be fluent in English or Spanish
* Have a role in the partner community clinic as either a) full-time or part-time employee b) intern c) volunteer

Exclusion Criteria:

\-

About the study

This is a mixed-methods Hybrid Type 1 research design (efficacy study) in which we aim to conduct a two-arm randomized controlled trial and an Implementation Focused Process Evaluation of a culturally-targeted video and referral screening tool.

In this study, the investigators aim to evaluate the efficacy of a culturally targeted video previously developed by the research team vs. a Spanish-language fact sheet from an established group on enhancing genetic counseling and testing uptake and psychosocial outcomes in Latina women at risk for hereditary breast and ovarian cancer.

The investigators will test the video's efficacy while also gathering data on the implementation and future sustainability of using the Risk Screening Tool (RST) and video in community clinics.

What is being tested

Sponsor: Georgetown University · Participants: 332 · Started: Jun 1, 2021

Contact the study team

Official record on ClinicalTrials.gov — NCT05130606

Locations in the U.S.

District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center, Washington D.C.
VirginiaVirginia Commonwealth University, Richmond

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.